Invention Grant
- Patent Title: Teneurin and cancer
- Patent Title (中): 神奈琳和癌症
-
Application No.: US13126802Application Date: 2009-11-06
-
Publication No.: US08642280B2Publication Date: 2014-02-04
- Inventor: Ruth Chiquet-Ehrismann , Daniela Kenzelmann Bro{hacek over (z)}
- Applicant: Ruth Chiquet-Ehrismann , Daniela Kenzelmann Bro{hacek over (z)}
- Applicant Address: CH Basel
- Assignee: Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
- Current Assignee: Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
- Current Assignee Address: CH Basel
- Agency: Hoxie & Associates LLC
- Priority: EP08168610 20081107
- International Application: PCT/EP2009/064723 WO 20091106
- International Announcement: WO2010/052288 WO 20100514
- Main IPC: G01N33/574
- IPC: G01N33/574
Abstract:
The present invention relates to a method for treating cancer, for instance brain tumors, in a subject by inhibiting a teneurin by administering to said subject a therapeutically effective amount of a modulator of said teneurin, for example a specific antibody or a siRNA. The present invention also encompasses methods of diagnosing cancer by measuring levels of teneurin.
Public/Granted literature
- US20110229494A1 TENEURIN AND CANCER Public/Granted day:2011-09-22
Information query
IPC分类:
